PRCP activators or recombinant PRCP might be more meaningful for translational medicine than gene modification and be helpful to clarify the pathophysiological changes if PRCP is activated/upregulated after ischemia or reperfusion instead of prior to ischemia. The gene discussed is PRCP; the disease is ischemia.